The association of active and passive smoking with peripheral arterial disease: Results from NHANES 1999-2004

Angiology

Volumn 60, Issue 3, 2009, Pages 335-345

  Agarwal, Shikhar ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Peripheral arterial disease; Secondhand smoking; Smoking

Indexed keywords

COTININE;

ADULT; AGED; ARTERY DISEASE; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CLASSIFICATION; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PASSIVE SMOKING; RISK ASSESSMENT; SELF REPORT; SMOKELESS TOBACCO; SMOKING; ANKLE BRACHIAL INDEX; BLOOD; CROSS-SECTIONAL STUDY; META ANALYSIS; MIDDLE AGED; PERIPHERAL VASCULAR DISEASE; RISK FACTOR; STATISTICS; UNITED STATES;

ADULT; AGED; ANKLE BRACHIAL INDEX; COTININE; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; MALE; META-ANALYSIS AS TOPIC; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; RISK FACTORS; SMOKING; STATISTICS AS TOPIC; TOBACCO SMOKE POLLUTION; UNITED STATES;

EID: 67849122398     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319708330526     Document Type: Article

References (65)

1. Willigendael EM, Teijink JA, Bartelink ML, et al. Influence of smoking on incidence and prevalence of peripheral arterial disease. J Vasc Surg. 2004 ; 40: 1158-1165.
2. Selvin E., Erlinger TP Prevalence of and risk factors of peripheral arterial disease in the United States. Results from the NHANES 1999-00. Circulation. 2004 ; 110: 738-743.
3. Allison MA, Criqui MH, McClelland RL, et al. The effect of novel cardiovascular risk factors on the ethnic-specific odds for peripheral arterial disease in the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol. 2006 ; 8: 1190-1197.
4. Vogt MT, Cauley JA, Kuller LH, Hulley SB Prevalence and correlates of lower extremity arterial disease in elderly women. Am J Epidemiol. 1993 ; 137: 559-568.
5. Murabito JM, D'Agostino RB, Silbershatz H., Wilson WF Intermittent claudication. A risk profile from The Framingham Heart Study. Circulation. 1997 ; 96: 44-49.
6. Curb JD, Masaki K., Rodriguez BL, et al. Peripheral artery disease and cardiovascular risk factors in the elderly. The Honolulu Heart Program. Arterioscler Thromb Vasc Biol. 1996 ; 16: 1495-1500.
7. Dormandy JA, Rutherford RB Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000 ; 31 (1 Pt 2). S1 - S296.
8. Price JF, Mowbray PI, Lee AJ, Rumley A., Lowe GD, Fowkes FG Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh Artery Study. Eur Heart J. 1999 ; 20: 344-353.
9. O'Hare AM, Katz R., Shlipak MG, Cushman M., Newman AB Mortality and cardiovascular risk across the ankle-arm index spectrum: results from the Cardiovascular Health Study. Circulation. 2006 ; 113: 388-393.
10. Barnoya J., Glantz SA Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation. 2005 ; 111: 2684-2698.
11. López MJ, Pérez-Ros M., Schiaffino A., et al. Mortality attributable to passive smoking in Spain, 2002. Tob Control. 2007 ; 16: 373-377.
12. Hill SE, Blakely T., Kawachi I., Woodward A. Mortality among lifelong nonsmokers exposed to secondhand smoke at home: cohort data and sensitivity analyses. Am J Epidemiol. 2007 ; 165: 530-540.
13. Gan Q., Smith KR, Hammond SK, Hu TW Disease burden of adult lung cancer and ischaemic heart disease from passive tobacco smoking in China. Tob Control. 2007 ; 16: 417-422.
14. Guo X., Li J., Pang W., et al. Sensitivity and specificity of ankle-brachial index for detecting angiographic stenosis of peripheral arteries. Circ J. 2008 ; 72: 605-610.
15. Niazi K., Khan TH, Easley KA Diagnostic utility of the two methods of ankle brachial index in the detection of peripheral arterial disease of lower extremities. Catheter Cardiovasc Interv. 2006 ; 68: 788-792.
16. Feigelson HS, Criqui MH, Fronek A., Langer RD, Molgaard CA Screening for peripheral arterial disease: the sensitivity, specificity, and predictive value of noninvasive tests in a defined population. Am J Epidemiol. 1994 ; 140: 526-534.
17. Lijmer JG, Hunink MG, van den Dungen JJ, Loonstra J., Smit AJ ROC analysis of noninvasive tests for peripheral arterial disease. Ultrasound Med Biol. 1996 ; 22: 391-398.
18. Ouriel K., McDonnell AE, Metz CE, Zarins CK Critical evaluation of stress testing in the diagnosis of peripheral vascular disease. Surgery. 1982 ; 91: 686-693.
19. Reich LM, Heiss G., Boland LL, Hirsch AT, Wu K., Folsom AR Ankle brachial index and hemostatic markers in the Atherosclerosis Risk in Communities (ARIC) study cohort. Vasc Med. 2007 ; 12: 267-273.
20. Alzamore MT, Baena-Diez JM, Sorribes M., et al. Peripheral Arterial Disease Study (PERART): prevalence and predictive values of asymptomatic peripheral arterial occlusive disease related to cardiovascular morbidity and mortality. BMC Public Health. 2007 ; 7: 348.
21. Available at: http://www.cdc.gov/nchs/nhanes.htm. Accessed April 3, 2008.
22. Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Arch Intern Med. 1998 ; 158: 1855-1867.
23. Levey AS, Coresh J, Balk E, et al. National Kidney Foundation. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification [published erratum appears in Ann Intern Med. 2003;139:605]. Ann Intern Med. 2003 ; 139: 137-147.
24. Coresh J., Selvin E., Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007 ; 298: 2038-2047. (Pubitemid 350074801)
25. Selvin S., Manzi J., Stevens LA, et al. Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NAHANES) 1988-1994, 1999-2004. Am J Kidney Dis. 2007 ; 50: 918-926.
26. Psaty PM, Furberg CD, Kuller LH, et al. Traditional risk factors and subclinical disease measures as predictors of first myocardial infarction in older adults. Arch Intern Med. 1999 ; 159: 1339-1347.
27. Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA. 2003 ; 290: 86-97.
28. Selvin E., Hirsch AT Contemporary risk factor control and walking dysfunction in individuals with peripheral arterial disease: NHANES 1999-2000. Atherosclerosis. 2008 ; 201 (2). 425-433.
29. U.S. Department of Health, Education and Welfare. Smoking and Health: Report of the Advisory committee to the Surgeon General of the Public Health Service Publication No. 1103. Washington, DC: US Government Printing Office ; 1964.
30. Peto R., Lopez AD, Boreham J., Thun M., Heath C. Jr. Mortality From Smoking in Developed Countries 1950-2000. Oxford: Oxford University Press ; 1994.
31. National Research Council (NRC) Committee on Passive Smoking. Environmental Tobacco Smoke: Measuring Exposure and Assessing Health Effects. Washington, DC: National Academy Press ; 1986.
32. US Environmental Protection Agency (EPA). Respiratory Health Effects of Passive Smoking: Lung Cancer and Other Disorders. Washington, DC: US Government Printing Office ; 1992. EPA/600/006F.
33. Pierce JP, Dwyer T., DiGiusto E., et al. Cotinine validation of self-reported smoking in commercially run community surveys. J Chron Dis. 1987 ; 40: 689-695.
34. Jarvis MJ, Turnstall-Pedoe H., Feyerabend C., Vesey C., Saloojee Y. Comparison of tests used to distinguish smokers from nonsmokers. Am J Public Health. 1987 ; 77: 1435-1438.
35. Kemmeren JM, Poppel GV, Verhoef P., Jarvis MJ Plasma cotinine: stability in smokers and validation of self-reported smoke exposure in nonsmokers. Environ Res. 1994 ; 66: 235-243.
36. Wall MA, Johnson J., Jacob P., Benowitz NL Cotinine in the serum, saliva and urine of non-smokers, passive smokers, and active smokers. Am J Pub Health. 1988 ; 78: 699-701.
37. Vartianen E., Seppälä T., Lillsunde P., Puska P. Validation of self-reported smoking by serum cotinine measurement in a community-based study. J Epidemiol Community Health. 2002 ; 56: 167-170.
38. Benowitz NL, Kuyt F., Jacob P. III, Jones RT, Osman AL Cotinine disposition and effects. Clin Pharmacol Ther. 1983 ; 34: 604-611.
39. Haley NJ, Axelrad CM, Tilton K. Validation of self-reported smoking behavior: biochemical analyses of cotinine and thiocynate. Am J Pub Health. 1983 ; 73: 1204-1207.
40. Pojer R., Whitfield JB, Poulos V., Eckhard IF, Richmond R., Hensley WJ Carboxyhemoglobin, cotinine, and thiocynate assay compared for distinguishing smokers from non-smokers. Clin Chem. 1984 ; 30: 1377-1380.
41. Kyerematen GA, Damiano MD, Dvorchik BH, Vesell ES Smoking induced changes in nicotine and its metabolites. Clin Pharmacol Ther. 1982 ; 32: 769-780.
42. Halvorsen B., Lund Sagen E., Ueland T., Aukrust P., Tonstad S. Effect of smoking cessation on markers of inflammation and endothelial cell activation among individuals with high risk for cardiovascular disease. Scand J Clin Lab Invest. 2007 ; 67: 604-611.
43. Blankenberg S., Barbaux S., Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis. 2003 ; 170: 191-203.
44. Blankenberg S., Rupprecht HJ, Bickel C., et al. Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation. 2001 ; 104: 1336-1342.
45. Perlstein TS, Lee RT Smoking, metalloproteinases, and vascular disease. Arterioscler Thromb Vasc Biol. 2006 ; 26: 250-256.
46. Celec P. Nuclear factor kappa B-molecular biomedicine: the next generation. Biomed Pharmacol. 2004 ; 58: 365-371.
47. Ridker PM, Cushman M., Stampfer MJ, Tracy RP, Hennekens CH Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997 ; 336: 973-979.
48. Wilson PW ; CDC; AHA. CDC/AHA Workshop on markers of inflammation and cardiovascular disease: application to clinical and public health practice: ability of inflammatory markers to predict disease in asymptomatic patients: a background paper. Circulation. 2004 ; 110: e568 - e571.
49. Danesh J., Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004 ; 350: 1387-1397.
50. Koenig W., Löwel H., Baumert J., Meisinger C. C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany. Circulation. 2004 ; 109: 1349-1353.
51. Fowkes FG, Housley E., Riemersma RA, et al. Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study. Am J Epidemiol. 1992 ; 135: 331-340.
52. Navas-Acien A., Selvin E., Sharrett R., Calderon-Aranda E., Silbergeld E., Guallar E. Lead, cadmium, smoking, and increased risk of peripheral arterial disease. Circulation. 2004 ; 109: 3196-3201.
53. Nerem RM, Levesque MJ Fluid dynamics as a factor in the localization of atherogenesis. Ann N Y Acad Sci. 1983 ; 416: 709-719.
54. Lowe GD Blood viscosity and cardiovascular disease. Thromb Haemost. 1992 ; 67: 494-498.
55. Meade TW, Imeson J., Stirling Y. Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease. Lancet. 1987 ; 2: 986-988.
56. Nerem RM, Alexander RW, Chappell DC, Medford RM, Varner SE, Taylor WR The study of the influence of flow on vascular endothelial biology. Am J Med Sci. 1998 ; 316: 169-175.
57. Jonason T., Bergstrom R. Cessation of smoking in patients with intermittent claudication: effects on the risk of peripheral vascular complications, myocardial infraction and mortality. Acta Med Scand. 1987 ; 221: 253-260.
58. Terry ML, Berkowitz HD, Kerstein MD Tobacco. Its impact on vascular disease. Surg Clin North Am. 1998 ; 78: 409-429.
59. Pirkle JL, Flegal KM, Bernert JT, Brody DJ, Etzel RA, Maurer KR Exposure of the US population to environmental tobacco smoke: the Third National Health and Nutrition Examination Survey, 1988 to 1991. JAMA. 1996 ; 275: 1233-1240.
60. Pirkle JL, Bernert JT, Caudil SP, Sosnoff CS, Pechacek TF Trends in the exposure of nonsmokers in the U.S. population to secondhand smoke: 1988-2002. Environ Health Perspect. 2006 ; 114: 853-858.
61. Shankar A., Li J., Nieto J., Klein BE, Klein R. Association between C-reactive protein level and peripheral arterial disease among US adults without cardiovascular disease, diabetes, or hypertension. Am Heart J. 2007 ; 154: 495-501.
62. Newman AB, Siscovick DS, Manolio RA, et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation. 1993 ; 88: 837-845.
63. Haley NJ, Colosimo SG, Axelrad CM, Harris R., Sepkovic DW Biochemical validation of self-reported exposure to environmental tobacco smoke. Environ Res. 1989 ; 49: 127-135.
64. Ridker PM, Hennekens CH, Roitman-Johnson B., Stampfer MJ, Allen J. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet. 1998 ; 351: 88-92.
65. Benowitz NL, Perez-Stable EJ, Fong I., Modin G., Herrera B., Jacob P. III. Ethnic differences in N-glucuronidation of nicotine and cotinine. J Pharmacol Exp Ther. 1999 ; 291: 1196-1203.